TCT-280 BIOFLOW-VI: BIOTRONIK—Safety and Clinical PerFormance of the Drug ELuting Orsiro Stent in the Treatment of Subjects With de novo Coronary Artery Lesions—VI: 2 Years Clinical Results
2019
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI